FOXA2 and colorectal carcinoma: Our findings not only revealed a novel link between FOXA2 and ferroptosis but also disclosed a novel mechanism of OXA resistance, suggesting that FOXA2 is a predictive factor with therapeutic potential for CRC treatment.